News Articles on 'Hematology'

Back to All Specialties


Hematology Researcher and Dean of Medicine Elected NAI Fellow

Newswise — STONY BROOK, N.Y., December 12, 2018 – Kenneth Kaushansky, MD, MACP, Senior Vice President of the Health Sciences and Dean of the Renaissance School of Medicine at Stony Brook University, has been elected a Fellow of the National Academy of ...

Source: Newswise
Published: 12 Dec 2018

Hematology Market Major Key Players 2023

Hematology describes a branch of medicine, which deals with the diagnosis, treatment and prevention of diseases associated with blood, immunology, vascular systems, bone marrow, and hemostasis. Hematological tests can identify various blood related ...

Source: openpr.com
Published: 12 Dec 2018

2018 Emerging Hematology and Flow Cytometry Technologies, Country Market Shares, Strategic Profiles of Leading Suppliers

LONDON, Dec. 10, 2018 /PRNewswire/ -- 2018 Emerging Hematology and Flow Cytometry Technologies, Country Market Shares, Strategic Profiles of Leading Suppliers Download the full report: https://www.reportbuyer.com/product/5297338 This 42-page report ...

Source: PR Newswire
Published: 10 Dec 2018

Center Will Be the First National-Scale Pediatric Oncology-Hematology Center in Georgia

BERKELEY, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- The U.S. Agency for International Development (USAID) has awarded a pivotal grant of $700,000 from its American Schools and Hospitals Abroad ...

Source: GlobeNewswire
Published: 11 Dec 2018

Use Of Gene Therapy In The Hematology Drugs Market

The global hematology drugs market size is expected to reach above $50 billion by 2021, growing at a CAGR of more than 6%. Going forward, unhealthy lifestyles leading to anemia and coagulation disorders, along with increased longevity and the launch of ...

Source: emailwire.com
Published: 10 Dec 2018

Roche Holding Ltd (RHHBY) Management Presents at 2018 American Society of Hematology's 60th Annual Meeting Conference (Transcript)

Roche Holding Ltd (OTCQX:RHHBY) 2018 American Society of Hematology’s 60th Annual Meeting Call December 4, 2018 2:00 PM ET Executives Karl Mahler - Head, Investor Relations Sandra Horning ...

Source: Seeking Alpha
Published: 05 Dec 2018

Top hematology/oncology stories: FDA approves Vitrakvi, ketogenic diet beneficial for ovarian cancer

Among the top stories in hematology/oncology this past week were the FDA approval of Vitrakvi for solid tumors with neurotrophic receptor tyrosine kinase gene fusion and trial results indicating that the ketogenic diet is superior to the diet recommended ...

Source: Healio
Published: 06 Dec 2018

Verastem Oncology Presents Duvelisib Development Program Data at the American Society of Hematology 2018 Annual Meeting

Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced the presentation of seven posters highlighting new and ...

Source: The Business Journals
Published: 04 Dec 2018

American Society of Hematology, Dec. 1-4

The annual meeting of the American Society of Hematology was held from Dec. 1 to 4 in San Diego and attracted approximately 22,000 participants from around the world, including hematology specialists, clinical practitioners, and other health care ...

Source: Doctors Lounge
Published: 08 Dec 2018

Amgen Inc. (AMGN) Presents at 60th American Society of Hematology (ASH) Annual Meeting Presentation (Transcript)

Amgen Inc. (NASDAQ:AMGN) 60th American Society of Hematology Annual Meeting December 3, 2018 11:00 PM ET Executives Arvind Sood - VP, IR Dr. David Reese - Head of R&D Dr. Greg Friberg - VP, Global ...

Source: Seeking Alpha
Published: 06 Dec 2018

City of Hope Clinical and Laboratory Investigators Present New Research at the 60th American Society of Hematology Meeting

DUARTE, Calif.--(BUSINESS WIRE)--Dec 4, 2018--City of Hope physicians and researchers at the American Society of Hematology (ASH) meeting in San Diego presented clinical trials for new leukemia and lymphoma treatments, laying the groundwork for innovative ...

Source: The Register-Herald
Published: 04 Dec 2018

Acceleron Announces Luspatercept Phase 3 MEDALIST and BELIEVE Presentations Selected for “Best of ASH” by the American Society of Hematology

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (Nasdaq:XLRN) today announced that the presentations of the MEDALIST and BELIEVE Phase 3 trial results of luspatercept in patients with ...

Source: NewsOK
Published: 06 Dec 2018

Bayer Presents Five-Year Outcomes Data from the PROTECT VIII Extension Study at the 60th American Society of Hematology Annual Meeting

WHIPPANY, N.J., Dec. 4, 2018 /PRNewswire/ -- Bayer announced findings from an analysis of the PROTECT VIII extension in which patients who received five years of prophylactic treatment with Jivi ® (BAY 94-9027, antihemophilic factor [recombinant ...

Source: PR Newswire
Published: 04 Dec 2018

Geron Reports Updated Results from Phase 2 Portion of IMerge at the 60th American Society of Hematology Annual Meeting

MENLO PARK, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (GERN) today announced that updated results from Part 1 of IMerge, the Phase 2 portion of a Phase 2/3 clinical trial of ...

Source: Yahoo Finance
Published: 03 Dec 2018

Comprehensive Positive Phase 3 Data for Alexion’s ALXN1210 in Patients with Paroxysmal Nocturnal Hemoglobinuria Presented at American Society of Hematology (ASH) Annual ...

SAN DIEGO--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the presentation of comprehensive positive Phase 3 data for ALXN1210, the company’s investigational long-acting C5 complement inhibitor, at the American Society of ...

Source: Business Wire
Published: 03 Dec 2018

NantKwest to Present Updated Preclinical Data at the 60th Annual Meeting of the American Society of Hematology

CULVER CITY, Calif.--(BUSINESS WIRE)--NantKwest Inc. (Nasdaq:NK), a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system ...

Source: NewsOK
Published: 04 Dec 2018

Poseida Therapeutics Provides Update on Phase 1 Study of P-BCMA-101 CAR-T Product Candidate at the 2018 American Society of Hematology Annual Meeting

P-BCMA-101 showed a 100% ORR with patients achieving rapid and deep responses with no CRS or neurotoxicity observed at the planned Phase 2 dose SAN DIEGO, Dec. 03, 2018 (GLOBE NEWSWIRE ...

Source: ForexTV
Published: 03 Dec 2018

Verastem Oncology Announces Presentation of Updated Duvelisib Combination Clinical Data in Peripheral T-Cell Lymphoma at the American Society of Hematology 2018 Annual Meeting

BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced an oral presentation highlighting ...

Source: Business Wire
Published: 04 Dec 2018

Stemline Therapeutics Recaps Key Clinical Data Presentations from the American Society of Hematology (ASH) Annual Meeting

• Median overall survival (OS) was not yet reached in first-line patients treated with ELZONRIS at 12 ug/kg/day across all stages. Median follow up time is 23.0 months (range of 0.2 ...

Source: GlobeNewswire
Published: 06 Dec 2018

Jazz Pharmaceuticals to Highlight Hematology Research at ASH 2018 Annual Meeting

Nine abstracts, including two oral presentations, accepted for Jazz hematology/oncology portfolio, focusing on leukemia and complications of stem cell transplantation DUBLIN, Nov. 28, 2018 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) announced today ...

Source: Yahoo Finance
Published: 28 Nov 2018

New York Oncology Hematology hit by email scam

ALBANY -- New York Oncology Hematology is providing credit reporting services to its nearly 130,000 patients and employees, after learning it was the victim of an apparent cyberattack. The health care provider said Friday that an outside forensic firm's ...

Source: The Daily Gazette
Published: 16 Nov 2018

Hematology Analyzer Market Growth by Manufactures, Types, Applications and Regions 2018-2025

This research report categorizes the global Hematology Analyzer market by top players/brands, region, type and end user. This report also studies the global Hematology Analyzer market status, competition landscape, market share, growth rate, future trends ...

Source: emailwire.com
Published: 21 Nov 2018

Stanford Review of the 60th Annual American Society of Hematology Meeting 2019

A Continuing Medical Education Conference presented by the Department of Medicine, Division of Hematology at the Stanford University School of Medicine. The 2019 Stanford Review of the 60th Annual ASH Conference will highlight cutting-edge research and ...

Source: med.stanford.edu
Published: 12 Nov 2018

Hematology Analyzer And Reagents Market Dynamics, Forecast, Analysis and Supply Demand 2017-2027

Future Market Insights has announced the addition of the “Hematology Analyzer And Reagents Market: Global Industry Analysis and Opportunity Assessment 2017-2027" report to their offering Hematology word comes from Greek ‘haima’ and ‘logos ...

Source: PMLiVE
Published: 09 Nov 2018

Ongoing Study Traces the Expansion of Hematology Analyzer and Reagents Market During 2017 - 2027

New York, NY -- (SBWIRE) -- 10/19/2018 -- Hematology word comes from Greek 'haima' and 'logos' meaning blood and discourse respectively. Hematology encompasses the science or study of blood cells and coagulation. Blood being the only fluid that flows ...

Source: Digital Journal
Published: 20 Oct 2018

Read Online Hoffman and Abeloff’s Hematology-Oncology Review By Claudine

DOWNLOAD NOW : http://dealsbooksyess889.blogspot.com/?q=Hoffman+and+Abeloff%27s+Hematology-Oncology+Review [PDF] Hoffman and Abeloff’s Hematology-Oncology Review PDF READ ONLINE [PDF] Hoffman and Abeloff’s Hematology-Oncology Review PDF Are you ...

Source: Medium
Published: 24 Sep 2018

Physician Leader in Field of Hematology Joins Morristown Hospital

This post was contributed by a community member. Award-winning physician-researcher Mohamad Cherry, MD, has joined Atlantic Hematology Oncology, part of Atlantic Health System's Atlantic Medical Group at the Carol G. Simon Cancer Center. Dr. Cherry, who is ...

Source: USA Patch
Published: 05 Jan 2018

Gift enables Vidant Health, ECU to partner in creating senior faculty positions in hematology/oncology

ECU and Vidant Health are partnering to create two senior faculty positions in the Division of Hematology and Oncology at ECU’s Brody School of Medicine. The positions are being funded by a generous gift to the Vidant Cancer Care campaign by Penny and ...

Source: The Daily Reflector
Published: 11 Jun 2018

BRIEF-Abbott Launches Alinity H-Series Integrated Hematology System

* ABBOTT LABORATORIES SAYS ANNOUNCED CE MARK FOR ALINITY H-SERIES INTEGRATED SYSTEM FOR HEMATOLOGY TESTING Source text for Eikon: Further company coverage: Our Standards:The Thomson Reuters Trust Principles.

Source: Reuters
Published: 02 Jan 2018